In the Treatment of Asthma, Merck’s Singulair Accounts for More Than a Quarter … – MarketWatch (press release)

In the Treatment of Asthma, Merck's Singulair Accounts for More Than a Quarter …
MarketWatch (press release)
Analysis of US patient-level claims data from Treatment Algorithms in Asthma also finds that more than half of newly diagnosed asthma patients that move to the second line of therapy within a year of diagnosis are treated with Singulair. …

and more »